BSX Boston Scientific Earnings and EPS analysis
- Stocks
- Healthcare
- NYSE: BSX
- Earnings
EPS in 2025 (TTM): $1.38
Last Report Period Date: Mar 31, 2025
Currently, BSX's 12-month EPS stands at $1.38, according to the most recent financial reports. Boston Scientific's earnings per share in 2024 was reported at $1.26, marking a rise from $1.08 in 2023. BSX recorded an EPS of $0.46 for the quarterly period ending on Mar 31, 2025.
BSX earnings history
In 2024, Boston Scientific's earnings per share was $1.26, a rise of 16.7% from $1.08 in 2023. The quarterly earnings per share for the period ending Mar 31, 2025, was $0.46, showing a 35.3% increase compared to the same quarter last year. The trailing twelve months EPS for BSX is $1.38 as of March 2025. Boston Scientific's full-year EPS for 2023 was $1.08, a 140% rise compared to the previous year.
BSX EPS growth
Over the past 12 months, Boston Scientific has recorded an earnings per share growth rate of 35.3% (YoY, quarterly). Over an extended period, the company recorded an average EPS annual growth rate of 22.2% per year for the last 3 years. In the last five years, the company had an average annual EPS growth of -17.9%.
BSX Earnings Waterfall
BSX Earnings vs Peers
| Stock name | Price to Earnings | EPS grwoth 1Y | EPS grwoth 3Y | EPS grwoth 5Y |
|---|---|---|---|---|
| EW Edwards Lifesciences Corp | 11 | 202.2% | 42.5% | 33% |
| CNMD CONMED Corp | 14.88 | 104.3% | 26.1% | 33.5% |
| MDT Medtronic plc | 26.3 | -2.1% | 1.1% | -4.2% |
| TFX Teleflex Inc | 37.6 | -80.3% | -47.6% | -31.7% |
| MMSI Merit Medical Systems Inc | 45.81 | 26.2% | 34% | 83.3% |
| SYK Stryker Corp | 51.54 | -5.8% | 14.1% | 7.1% |
| BSX Boston Scientific Corp | 74.37 | 16.7% | 22.2% | -17.9% |
| ANGO Angiodynamics Inc | N/A | -245.1% | N/A | N/A |
All data is based on quarterly TTM periods, unless otherwise specified.